ID   CRYAA_BOVIN             Reviewed;         173 AA.
AC   P02470;
DT   21-JUL-1986, integrated into UniProtKB/Swiss-Prot.
DT   21-JUL-1986, sequence version 1.
DT   28-JAN-2026, entry version 171.
DE   RecName: Full=Alpha-crystallin A chain;
DE   Contains:
DE     RecName: Full=Alpha-crystallin A(1-172);
DE   Contains:
DE     RecName: Full=Alpha-crystallin A(1-168);
GN   Name=CRYAA; Synonyms=CRYA1;
OS   Bos taurus (Bovine).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Laurasiatheria; Artiodactyla; Ruminantia; Pecora; Bovidae;
OC   Bovinae; Bos.
OX   NCBI_TaxID=9913;
RN   [1]
RP   PROTEIN SEQUENCE.
RX   PubMed=4770792; DOI=10.1111/j.1432-1033.1973.tb03119.x;
RA   van der Ouderaa F.J., de Jong W.W., Bloemendal H.;
RT   "The amino-acid sequence of the alphaA2 chain of bovine alpha-crystallin.";
RL   Eur. J. Biochem. 39:207-222(1973).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=3675580; DOI=10.1016/0006-291x(87)91072-2;
RA   Hay R.E., Petrash J.M.;
RT   "Nucleotide sequence of a bovine lens alpha A-crystallin cDNA.";
RL   Biochem. Biophys. Res. Commun. 148:31-37(1987).
RN   [3]
RP   PROTEIN SEQUENCE, ACETYLATION AT MET-1, AND PHOSPHORYLATION AT SER-122.
RX   PubMed=2042736; DOI=10.1016/0003-2697(91)90050-4;
RA   Smith J.B., Thevenon-Emeric G., Simth D.L., Green B.;
RT   "Elucidation of the primary structures of proteins by mass spectrometry.";
RL   Anal. Biochem. 193:118-124(1991).
RN   [4]
RP   GLYCOSYLATION AT SER-162.
RX   PubMed=1730617; DOI=10.1016/s0021-9258(18)48530-4;
RA   Roquemore E.P., Dell A., Morris H.R., Panico M., Reason A.J., Savoy L.-A.,
RA   Wistow G.J., Zigler J.S. Jr., Earles B.J., Hart G.W.;
RT   "Vertebrate lens alpha-crystallins are modified by O-linked N-
RT   acetylglucosamine.";
RL   J. Biol. Chem. 267:555-563(1992).
RN   [5]
RP   GLYCATION AT LYS-11 AND LYS-78, AND IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=7912928; DOI=10.1006/bbrc.1994.1866;
RA   Abraham E.C., Cherian M., Smith J.B.;
RT   "Site selectivity in the glycation of alpha A- and alpha B-crystallins by
RT   glucose.";
RL   Biochem. Biophys. Res. Commun. 201:1451-1456(1994).
RN   [6]
RP   PROTEOLYTIC PROCESSING.
RX   PubMed=8529423; DOI=10.3109/02713689508995806;
RA   Takemoto L.J.;
RT   "Identification of the in vivo truncation sites at the C-terminal region of
RT   alpha-A crystallin from aged bovine and human lens.";
RL   Curr. Eye Res. 14:837-841(1995).
RN   [7]
RP   X-RAY CRYSTALLOGRAPHY (1.15 ANGSTROMS) OF 59-163 IN COMPLEX WITH ZINC,
RP   FUNCTION, AND SUBUNIT.
RX   PubMed=20440841; DOI=10.1002/pro.380;
RA   Laganowsky A., Benesch J.L., Landau M., Ding L., Sawaya M.R., Cascio D.,
RA   Huang Q., Robinson C.V., Horwitz J., Eisenberg D.;
RT   "Crystal structures of truncated alphaA and alphaB crystallins reveal
RT   structural mechanisms of polydispersity important for eye lens function.";
RL   Protein Sci. 19:1031-1043(2010).
CC   -!- FUNCTION: Contributes to the transparency and refractive index of the
CC       lens (By similarity). Acts as a chaperone, preventing aggregation of
CC       various proteins under a wide range of stress conditions
CC       (PubMed:20440841). Required for the correct formation of lens
CC       intermediate filaments as part of a complex composed of BFSP1, BFSP2
CC       and CRYAA (By similarity). {ECO:0000250|UniProtKB:P02489,
CC       ECO:0000269|PubMed:20440841}.
CC   -!- SUBUNIT: Heteromer composed of three CRYAA and one CRYAB subunits (By
CC       similarity). Inter-subunit bridging via zinc ions enhances stability,
CC       which is crucial as there is no protein turn over in the lens (By
CC       similarity) (PubMed:20440841). Can also form homodimers and
CC       homotetramers (dimers of dimers) which serve as the building blocks of
CC       homooligomers. Within homooligomers, the zinc-binding motif is created
CC       from residues of 3 different molecules. His-100 and Glu-102 from one
CC       molecule are ligands of the zinc ion, and His-107 and His-154 residues
CC       from additional molecules complete the site with tetrahedral
CC       coordination geometry (PubMed:20440841). Part of a complex required for
CC       lens intermediate filament formation composed of BFSP1, BFSP2 and CRYAA
CC       (By similarity). {ECO:0000250|UniProtKB:P02489,
CC       ECO:0000269|PubMed:20440841}.
CC   -!- INTERACTION:
CC       P02470; P02510: CRYAB; NbExp=4; IntAct=EBI-15796552, EBI-7824601;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:P02489}. Nucleus
CC       {ECO:0000250|UniProtKB:P02489}. Note=Translocates to the nucleus during
CC       heat shock and resides in sub-nuclear structures known as SC35 speckles
CC       or nuclear splicing speckles. {ECO:0000250|UniProtKB:P02489}.
CC   -!- PTM: Acetylation at Lys-70 may increase chaperone activity.
CC       {ECO:0000250|UniProtKB:P02489}.
CC   -!- PTM: Undergoes age-dependent proteolytical cleavage at the C-terminus.
CC       {ECO:0000269|PubMed:8529423}.
CC   -!- SIMILARITY: Belongs to the small heat shock protein (HSP20) family.
CC       {ECO:0000255|PROSITE-ProRule:PRU00285}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; M26142; AAA30471.1; -; mRNA.
DR   PIR; A29656; CYBOA.
DR   RefSeq; NP_776714.1; NM_174289.2.
DR   PDB; 3L1E; X-ray; 1.15 A; A=59-163.
DR   PDB; 3L1F; X-ray; 1.53 A; A=62-163.
DR   PDBsum; 3L1E; -.
DR   PDBsum; 3L1F; -.
DR   AlphaFoldDB; P02470; -.
DR   BMRB; P02470; -.
DR   EMDB; EMD-7969; -.
DR   SMR; P02470; -.
DR   DIP; DIP-58566N; -.
DR   FunCoup; P02470; 210.
DR   IntAct; P02470; 1.
DR   STRING; 9913.ENSBTAP00000004073; -.
DR   CarbonylDB; P02470; -.
DR   GlyConnect; 32; 1 O-GlcNAc glycan (1 site).
DR   GlyConnect; 35; 1 O-GlcNAc glycan (1 site).
DR   GlyConnect; 36; 1 O-GlcNAc glycan (1 site).
DR   GlyCosmos; P02470; 3 sites, 1 glycan.
DR   GlyGen; P02470; 2 sites, 1 O-linked glycan (2 sites).
DR   iPTMnet; P02470; -.
DR   PaxDb; 9913-ENSBTAP00000004073; -.
DR   Ensembl; ENSBTAT00000004073.4; ENSBTAP00000004073.3; ENSBTAG00000003134.4.
DR   Ensembl; ENSBTAT00085010537; ENSBTAP00085008108; ENSBTAG00085025882.
DR   Ensembl; ENSBTAT00090015446; ENSBTAP00090007482; ENSBTAG00090008221.
DR   GeneID; 281718; -.
DR   KEGG; bta:281718; -.
DR   CTD; 1409; -.
DR   VEuPathDB; HostDB:ENSBTAG00000003134; -.
DR   eggNOG; KOG3591; Eukaryota.
DR   GeneTree; ENSGT00940000160159; -.
DR   HOGENOM; CLU_095001_2_0_1; -.
DR   InParanoid; P02470; -.
DR   OMA; QQDDHGY; -.
DR   OrthoDB; 1431247at2759; -.
DR   EvolutionaryTrace; P02470; -.
DR   Proteomes; UP000009136; Chromosome 1.
DR   Bgee; ENSBTAG00000003134; Expressed in pigment epithelium of eye and 14 other cell types or tissues.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IEA:Ensembl.
DR   GO; GO:0005654; C:nucleoplasm; IEA:Ensembl.
DR   GO; GO:0005634; C:nucleus; ISS:UniProtKB.
DR   GO; GO:0032991; C:protein-containing complex; IEA:Ensembl.
DR   GO; GO:0042802; F:identical protein binding; IEA:Ensembl.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0005212; F:structural constituent of eye lens; IEA:UniProtKB-KW.
DR   GO; GO:0051082; F:unfolded protein binding; IDA:UniProtKB.
DR   GO; GO:0007015; P:actin filament organization; IEA:Ensembl.
DR   GO; GO:0060561; P:apoptotic process involved in morphogenesis; IEA:Ensembl.
DR   GO; GO:0048596; P:embryonic camera-type eye morphogenesis; IEA:Ensembl.
DR   GO; GO:0006750; P:glutathione biosynthetic process; IEA:Ensembl.
DR   GO; GO:0002088; P:lens development in camera-type eye; IBA:GO_Central.
DR   GO; GO:0070309; P:lens fiber cell morphogenesis; IEA:Ensembl.
DR   GO; GO:0007017; P:microtubule-based process; IEA:Ensembl.
DR   GO; GO:0007005; P:mitochondrion organization; IEA:Ensembl.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; IBA:GO_Central.
DR   GO; GO:0010629; P:negative regulation of gene expression; IEA:Ensembl.
DR   GO; GO:0032387; P:negative regulation of intracellular transport; IEA:Ensembl.
DR   GO; GO:0030307; P:positive regulation of cell growth; IEA:Ensembl.
DR   GO; GO:0050821; P:protein stabilization; IEA:Ensembl.
DR   GO; GO:0009408; P:response to heat; IBA:GO_Central.
DR   GO; GO:0042542; P:response to hydrogen peroxide; IEA:Ensembl.
DR   GO; GO:0001666; P:response to hypoxia; IEA:Ensembl.
DR   GO; GO:0070141; P:response to UV-A; IEA:Ensembl.
DR   GO; GO:0007021; P:tubulin complex assembly; IEA:Ensembl.
DR   GO; GO:0007601; P:visual perception; IEA:Ensembl.
DR   FunFam; 2.60.40.790:FF:000008; Alpha-crystallin A chain; 1.
DR   Gene3D; 2.60.40.790; -; 1.
DR   InterPro; IPR002068; A-crystallin/Hsp20_dom.
DR   InterPro; IPR055269; Alpha-crystallin/HSP_16.
DR   InterPro; IPR001436; Alpha-crystallin/sHSP_animal.
DR   InterPro; IPR003090; Alpha-crystallin_N.
DR   InterPro; IPR008978; HSP20-like_chaperone.
DR   PANTHER; PTHR45640:SF14; ALPHA-CRYSTALLIN A CHAIN; 1.
DR   PANTHER; PTHR45640; HEAT SHOCK PROTEIN HSP-12.2-RELATED; 1.
DR   Pfam; PF00525; Crystallin; 1.
DR   Pfam; PF00011; HSP20; 1.
DR   PIRSF; PIRSF036514; Sm_HSP_B1; 1.
DR   PRINTS; PR00299; ACRYSTALLIN.
DR   SUPFAM; SSF49764; HSP20-like chaperones; 1.
DR   PROSITE; PS01031; SHSP; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Chaperone; Cytoplasm; Direct protein sequencing;
KW   Eye lens protein; Glycation; Glycoprotein; Metal-binding; Methylation;
KW   Nucleus; Phosphoprotein; Reference proteome; Zinc.
FT   CHAIN           1..173
FT                   /note="Alpha-crystallin A chain"
FT                   /id="PRO_0000125848"
FT   CHAIN           1..172
FT                   /note="Alpha-crystallin A(1-172)"
FT                   /id="PRO_0000226605"
FT   CHAIN           1..168
FT                   /note="Alpha-crystallin A(1-168)"
FT                   /id="PRO_0000423502"
FT   DOMAIN          52..162
FT                   /note="sHSP"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00285"
FT   REGION          1..63
FT                   /note="Required for complex formation with BFSP1 and BFSP2"
FT                   /evidence="ECO:0000250|UniProtKB:P02489"
FT   REGION          144..173
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          157..163
FT                   /note="Important for oligomerization"
FT   COMPBIAS        153..167
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         100
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000269|PubMed:20440841"
FT   BINDING         102
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000269|PubMed:20440841"
FT   BINDING         107
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000305|PubMed:20440841"
FT   BINDING         154
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="3"
FT                   /evidence="ECO:0000305|PubMed:20440841"
FT   SITE            70
FT                   /note="Not glycated"
FT   SITE            88
FT                   /note="Not glycated"
FT   SITE            99
FT                   /note="Not glycated"
FT   SITE            145
FT                   /note="Not glycated"
FT   SITE            166
FT                   /note="Not glycated"
FT   MOD_RES         1
FT                   /note="N-acetylmethionine"
FT                   /evidence="ECO:0000269|PubMed:2042736"
FT   MOD_RES         6
FT                   /note="Deamidated glutamine; partial"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         45
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P02489"
FT   MOD_RES         50
FT                   /note="Deamidated glutamine; partial"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         70
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P02489"
FT   MOD_RES         90
FT                   /note="Deamidated glutamine; partial"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         99
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P02489"
FT   MOD_RES         101
FT                   /note="Deamidated asparagine; partial"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         122
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:2042736"
FT   MOD_RES         123
FT                   /note="Deamidated asparagine; partial"
FT                   /evidence="ECO:0000250"
FT   CARBOHYD        11
FT                   /note="N-linked (Glc) (glycation) lysine"
FT                   /evidence="ECO:0000269|PubMed:7912928"
FT   CARBOHYD        78
FT                   /note="N-linked (Glc) (glycation) lysine"
FT                   /evidence="ECO:0000269|PubMed:7912928"
FT   CARBOHYD        162
FT                   /note="O-linked (GlcNAc) serine"
FT                   /evidence="ECO:0000269|PubMed:1730617"
FT                   /id="CAR_000056"
FT   STRAND          61..66
FT                   /evidence="ECO:0007829|PDB:3L1E"
FT   STRAND          68..76
FT                   /evidence="ECO:0007829|PDB:3L1E"
FT   HELIX           82..84
FT                   /evidence="ECO:0007829|PDB:3L1E"
FT   STRAND          85..90
FT                   /evidence="ECO:0007829|PDB:3L1E"
FT   STRAND          93..104
FT                   /evidence="ECO:0007829|PDB:3L1E"
FT   TURN            105..107
FT                   /evidence="ECO:0007829|PDB:3L1E"
FT   STRAND          108..119
FT                   /evidence="ECO:0007829|PDB:3L1E"
FT   STRAND          130..133
FT                   /evidence="ECO:0007829|PDB:3L1E"
FT   STRAND          137..145
FT                   /evidence="ECO:0007829|PDB:3L1E"
FT   TURN            150..153
FT                   /evidence="ECO:0007829|PDB:3L1E"
FT   STRAND          154..156
FT                   /evidence="ECO:0007829|PDB:3L1E"
SQ   SEQUENCE   173 AA;  19790 MW;  7796ED1B71864478 CRC64;
     MDIAIQHPWF KRTLGPFYPS RLFDQFFGEG LFEYDLLPFL SSTISPYYRQ SLFRTVLDSG
     ISEVRSDRDK FVIFLDVKHF SPEDLTVKVQ EDFVEIHGKH NERQDDHGYI SREFHRRYRL
     PSNVDQSALS CSLSADGMLT FSGPKIPSGV DAGHSERAIP VSREEKPSSA PSS
//
